Literature DB >> 8116926

Comparative effects of xylazine and propofol on the urethral pressure profile of healthy dogs.

H Combrisson1, G Robain, J P Cotard.   

Abstract

The effects of 2 drugs, xylazine and propofol, on the urethral pressure profile were compared. Seven female dogs were sedated by administration of one drug, then the other, and urethral variables were measured. In the dogs sedated with propofol, the mean +/- SD, maximal urethral closure pressure (51 +/- 7.4 cm of H2O) was significantly (P < 0.05) higher than the value when dogs were sedated with xylazine (23.3 +/- 7.6 cm of H2O). Results were compared with those obtained by various authors, in particular for nonsedated dogs. It is concluded that propofol is a good drug for investigation of the urethral pressure profile, whatever its effect on maximal urethral closure pressure.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8116926

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  4 in total

1.  Effects of anesthetics on cystometric parameters in female rats.

Authors:  Cuneyd Ozkurkcugil; Levend Ozkan
Journal:  Int Urol Nephrol       Date:  2010-05-13       Impact factor: 2.370

2.  High rates of postoperative urinary retention following primary total hip replacement performed under combined general and spinal anaesthesia with intrathecal opiate.

Authors:  Michael David; Elizabeth Arthur; Raveena Dhuck; Ellie Hemmings; David Dunlop
Journal:  J Orthop       Date:  2015-11-18

3.  Incidence, Outcomes, and Prediction of Postoperative Urinary Retention After a Nonurologic Procedure.

Authors:  Haidar M Abdul-Muhsin; Nicholas Jakob; Stephen Cha; Nan Zhang; Adam Schwartz; Anojan Navaratnam; Aqsa Khan; Mitchell Humphreys
Journal:  J Am Acad Orthop Surg Glob Res Rev       Date:  2020-05

4.  Effect of Sedation Anesthesia With Intravenous Propofol on Transrectal Ultrasound-Guided Prostate Biopsy Outcomes.

Authors:  Hee Youn Kim; Young Hyo Choi; Seung-Ju Lee
Journal:  J Korean Med Sci       Date:  2022-04-18       Impact factor: 5.354

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.